Sage’s Dalzanemdor Prospects In Doubt After First Mid-Stage Readout

Three More Phase II Trials Under Way

Question mark heap on table concept for confusion, question or solution
Parkinson's data raise questions about studies in other indications • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D